Michael Weber, MD

Professor of Medicine
SUNY Downstate Medical College
Palm Beach Gardens, Florida, United States

Michael A. Weber, MD is Professor of Medicine at the SUNY Downstate College of Medicine in Brooklyn, New York.

His career has been focused primarily on hypertension and preventive cardiology. He has published numerous research articles and has authored or edited 16 books.

He is the Editor-in-Chief of The Journal of Clinical Hypertension. He is a Fellow of The American College of Physicians, The American College of Cardiology and The American Heart Association. He has served on the Cardiovascular and Renal Drugs Advisory Board of the FDA, and continues as a consultant

His main research interests are in clinical trials of patients at high risk of cardiovascular events or strokes. He also participates actively in trials in patients with metabolic disorders such as diabetes and kidney disease. Dr. Weber currently serves on the Steering Committees of several national and international clinical outcomes trials.

Presentation(s):

• CARDIOTUBE INTERVIEW: Latest Data from the RDN Studies

  Sunday, February 26, 2023
  8:45 AM – 8:55 AM ET

  Disclosure information not submitted.

• HYPERTENSION DEFINITION, PATHOPHYSIOLOGY, NEW TARGETS AND MEDICAL THERAPY

  Sunday, February 26, 2023
  9:35 AM – 10:30 AM ET

  Disclosure(s): Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)

• Moment of truth- How are we Doing Helping our Patients Control Their Blood Pressure?

  Sunday, February 26, 2023
  9:35 AM – 9:43 AM ET

  Disclosure(s): Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)

• Uncontrolled Hypertension Management Issues: Adherence, Testing and Difficult to Control Patients Tips and Tricks

  Sunday, February 26, 2023
  9:59 AM – 10:07 AM ET

  Disclosure(s): Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)

• Panel Discussion: Best Practice for Establishing a HTN Patient Care Medical Based Pathway

  Sunday, February 26, 2023
  10:15 AM – 10:30 AM ET

  Disclosure(s): Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)

• RENAL DENERVATION: NEW DATA FROM THE LATEST PIVOTAL TRIALS

  Sunday, February 26, 2023
  10:30 AM – 12:00 PM ET

  Disclosure(s): Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)

• Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation

  Sunday, February 26, 2023
  11:50 AM – 12:00 PM ET

  Disclosure(s): Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)